Guideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the United Kingdom Haemophilia Centre Doctors' Organisation and the British Society for Haematology
Br J Haematol
.
2024 May;204(5):1714-1731.
doi: 10.1111/bjh.19385.
Epub 2024 Mar 26.
Authors
Sean Platton
1
,
Peter Baker
2
,
Annette Bowyer
3
,
Catriona Keenan
4
,
Caroline Lawrence
5
,
Will Lester
6
,
Anne Riddell
7
,
Megan Sutherland
8
Affiliations
1
Royal London Hospital Haemophilia Centre, London, UK.
2
Oxford Haemophilia and Thrombosis Centre, Nuffield Orthopaedic Hospital, Oxford, UK.
3
Department of Coagulation, Royal Hallamshire Hospital, Sheffield, UK.
4
Department of Haematology & the National Coagulation Centre, St. James's Hospital, Dublin, Ireland.
5
Department of Haematology, Glasgow Royal Infirmary, Glasgow, UK.
6
Haemophilia Unit, University Hospitals, Birmingham, UK.
7
Katharine Dormandy Haemophilia Centre, Royal Free Hospital, London, UK.
8
North West Genomic Laboratory Hub, Manchester University NHS Foundation Trust, Manchester, UK.
PMID:
38532595
DOI:
10.1111/bjh.19385
No abstract available
Keywords:
VWD; VWF; bleeding disorders; genetic analysis; genetic disorders; laboratory haematology.
Publication types
Practice Guideline
MeSH terms
Humans
United Kingdom
von Willebrand Diseases* / diagnosis
von Willebrand Factor / analysis
Substances
von Willebrand Factor